Literature DB >> 2240710

Optimization of pulse train duration for the electrical stimulation of a skeletal muscle ventricle in the dog.

S F Badylak1, J E Wessale, L A Geddes, W Janas.   

Abstract

The optimal means of electrically stimulating a skeletal muscle to contract around a fluid-filled pouch (i.e., a skeletal muscle ventricle [SMV]) has not been determined. A SMV was made from the latissimus dorsi muscle in five dogs and the rectus abdominis muscle in five dogs, and each SMV was electrically stimulated via the motor nerve(s) to contract around a fluid-filled pouch, which was connected to a mock circulatory system. The pulse train duration (PTD) was varied from 100 ms to 800 ms in 100 ms increments to determine the effect of this variable upon SMV output. The pulse width of the electrical stimulus was kept constant at 100 microseconds and the pulse frequency was maintained at 50 s-1. For SMV contraction rates of 20, 30, and 40 min-1, the optimal PTD was 400 ms for both muscles. The peak output was 710 ml min-1 for the rectus SMV and 556 ml min-1 for the latissimus SMV. For an SMV contraction rate of 10 min-1, the optimal PTD was 800 ms for the rectus SMV and 600 ms for the latissimus SMV. Use of less than an optimal PTD caused reductions in SMV output of 25-50%. Although SMVs made from rectus abdominis and latissimus dorsi had similar values for the optimal PTD, the maximum SMV output was usually greater with the rectus abdominis in this acute study with untrained muscles. We conclude that PTD is an important variable to control, which can markedly affect results when studying the potential use of skeletal muscle power for cardiac assistance.

Entities:  

Mesh:

Year:  1990        PMID: 2240710     DOI: 10.1007/bf02364611

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  27 in total

1.  The use of diaphragm grafts for plastic operations in thoracic surgery.

Authors:  B V PETROVSKY
Journal:  J Thorac Cardiovasc Surg       Date:  1961-03       Impact factor: 5.209

2.  The use of electrically stimulated skeletal muscle to pump blood.

Authors:  L A Geddes; S F Badylak; J l Wessale; W Janas; J D Bourland; W A Tacker; L Stevens
Journal:  Pacing Clin Electrophysiol       Date:  1990-03       Impact factor: 1.976

3.  Significance of impulse activity in the transformation of skeletal muscle type.

Authors:  S Salmons; F A Sréter
Journal:  Nature       Date:  1976-09-02       Impact factor: 49.962

4.  A skeletal muscle ventricle made from rectus abdominis muscle in the dog.

Authors:  L Stevens; S F Badylak; W Janas; M Gray; L A Geddes; W D Voorhees
Journal:  J Surg Res       Date:  1989-01       Impact factor: 2.192

5.  Hydraulic pouches of canine latissimus dorsi. Potential for left ventricular assistance.

Authors:  J D Mannion; R Hammond; L W Stephenson
Journal:  J Thorac Cardiovasc Surg       Date:  1986-04       Impact factor: 5.209

6.  The Registry of the International Society for Heart Transplantation: third official report--June 1986.

Authors:  E Solis; M P Kaye
Journal:  J Heart Transplant       Date:  1986 Jan-Feb

7.  Myocardial substitution with a stimulated skeletal muscle: first successful clinical case.

Authors:  A Carpentier; J C Chachques
Journal:  Lancet       Date:  1985-06-01       Impact factor: 79.321

8.  Electrical conditioning of in situ skeletal muscle for replacement of myocardium.

Authors:  J A Macoviak; L W Stephenson; F Armenti; A M Kelly; A Alavi; T Mackler; J Cox; G Palatianos; L H Edmunds
Journal:  J Surg Res       Date:  1982-05       Impact factor: 2.192

9.  Cardiac assistance with electrically stimulated skeletal muscle.

Authors:  S F Badylak; L Stevens; W Janas; M H Gray; L A Geddes; W D Voorhees
Journal:  Med Biol Eng Comput       Date:  1989-03       Impact factor: 2.602

10.  Comparison of three methods of electrical stimulation for converting skeletal muscle to a fatigue resistant power source suitable for cardiac assistance.

Authors:  S F Badylak; M Hinds; L A Geddes
Journal:  Ann Biomed Eng       Date:  1990       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.